6-Thio-2-Deoxyguanosine is a nucleoside analogue that can be incorporated into de novo-synthesized telomeres by telomerase.
性状
Solid
IC50 & Target[1][2]
DNA/RNA Synthesis
体外研究(In Vitro)
Treatment with 6-Thio-2-Deoxyguanosine results in rapid cell death for the vast majority of the cancer cell lines tested with IC50s of between 0.7-2.9 μM.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
In A549 lung cancer cell-based mouse xenograft studies, 6-Thio-2-Deoxyguanosine causes a decrease of the tumor growth rate, superior to that observed with 6-thioguanine treatment. Additionally, 6-Thio-2-Deoxyguanosine increases telomere dysfunction in tumor cells in vivo.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.